RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.
President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services is one ...
BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...
The Sunday Business Post17h
RFK Jr’s appointment sparks vaccine stock plunge: what it means for investors and Ireland
Vaccine and other healthcare stocks retreated sharply on Friday after RFK was selected to lead the US health and human ...
Heard on the Street Monday Recap: RFK Bridge to Nowhere
Friday was a doozy for many biotech and pharmaceutical companies after news broke late Thursday that President-elect Donald Trump would nominate vaccine skeptic Robert F. Kennedy Jr. to the nation's ...
FiercePharma21h
Despite fears over RFK Jr. pick, industry should focus more on FDA job: analyst
While RFK Jr. has recently attempted to dilute his controversial vaccine beliefs, emphasizing in an interview that "we're not ...
RFK Jr. is Trump's pick to lead HHS — here's what he could do with that power
Trump’s selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries ...
Trump Wants RFK Jr. to ‘Go Wild’ on Healthcare. Investors Need Not Panic.
The vaccine skeptic may find it hard to enact earth-shattering changes to American healthcare.
Bullish On Bavarian Nordic's Vaccine Portfolio And Revenue Potential In 2025
Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for ...
Science News4h
Vaccines, fluoride, raw milk: How RFK Jr.’s views may shape public health
If confirmed as head of the Department of Health and Human Services, Kennedy could influence U.S. policy on vaccines, drugs and food safety.